Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | F11 | P03951 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 4/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.34 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8264491 | 0.80 | AR (0.51) | KIF11CA12CA9CA1CA3 | |
| SCHEMBL8567454 | 0.76 | ITK (0.48) | KIF11AR | |
| SCHEMBL11857777 | 0.74 | KIF11 (0.51) | KIF11CA12CA9CA1CA3 | |
| SCHEMBL3661475 | 0.73 | ALDH1A1 (0.62) | MAPK1MAPTKDM4EMEN1APAF1 | |
| SCHEMBL8059743 | 0.70 | AR (0.55) | KIF11CA12CA9CA1CA3 | |
| SCHEMBL4300332 | 0.70 | ITK (0.47) | CA12CA9CA1CA3CA4 | |
| SCHEMBL3594957 | 0.69 | MAOA (0.52) | KIF11MAPTKDM4EMEN1ALDH1A1 | |
| SCHEMBL1775364 | 0.67 | KIF11 (0.45) | KIF11CA12CA9CA1CA3 | |
| SCHEMBL17951770 | 0.66 | MAPK1 (0.68) | KIF11CA12CA9CA1CA3 | |
| SCHEMBL18517520 | 0.66 | HK1 (0.39) | KIF11CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190008857-A1 | Method and Therapeutic/Cosmetic Topical Compositions for the Treatment of Rosacea and Skin Erythema Using A1-Adrenoceptor Agonists | ASPECT PHARMACEUTICALS LLC | 2019-01-10 | — | — | US | disclosed |
| US-20180360827-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ASPECT PHARMACEUTICALS LLC | 2018-12-20 | — | — | US | disclosed |
| US-20170231985-A9 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ALLERGAN, INC. | 2017-08-17 | — | — | US | disclosed |
| US-20160082007-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ALLERGAN, INC. | 2016-03-24 | — | — | US | disclosed |
| US-20150272948-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ALLERGAN, INC. | 2015-10-01 | — | — | US | disclosed |
| US-8877793-B2 | Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists | ALLERGAN, INC. (US) | 2014-11-04 | — | — | US | disclosed |
| US-8815929-B2 | Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists | ALLERGAN, INC. (US) | 2014-08-26 | — | — | US | disclosed |
| US-20130195944-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ALLERGAN, INC. (US) | 2013-08-01 | — | — | US | disclosed |
| US-20130195943-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ALLERGAN, INC. (US) | 2013-08-01 | — | — | US | disclosed |
| US-8420688-B2 | Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists | ALLERGAN, INC. (US) | 2013-04-16 | — | — | US | disclosed |
| US-20110034423-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | VICEPT THERAPEUTICS, INC. (US) | 2011-02-10 | — | — | US | disclosed |
| US-20110027201-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | VICEPT THERAPEUTICS, INC. (US) | 2011-02-03 | — | — | US | disclosed |
| US-7812049-B2 | alpha 1-adrenoceptor agonists for treating skin redness; oxymetazoline hydrochloride | VICEPT THERAPEUTICS, INC. (US) | 2010-10-12 | — | — | US | disclosed |
| US-20100233109-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | VICEPT THERAPEUTICS, INC. (US) | 2010-09-16 | — | — | US | disclosed |
| US-20050165079-A1 | alpha 1-adrenoceptor agonists for treating skin redness; oxymetazoline hydrochloride | EPI HEALTH, LLC | 2005-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150272948-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ADRA1A, ADRA2A, ADRA1D | KIF11 3234/4885CA12 4153/4885CA9 3782/4885 |
| US-20050165079-A1 | alpha 1-adrenoceptor agonists for treating skin redness; oxymetazoline hydrochloride | ADRA1A, ADRA1D, ADRA2A | KIF11 2848/4885CA12 4648/4885CA9 4181/4885 |
| US-20170231985-A9 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ADRA1A, ADRA2A, ADRA1D | KIF11 3234/4885CA12 4153/4885CA9 3782/4885 |
| US-20180360827-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ADRA1A, ADRA2A, ADRA1D | KIF11 2796/4885CA12 3650/4885CA9 3987/4885 |
| US-20130195943-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ADRA1A, ADRA2A, ADRA1D | KIF11 3234/4885CA12 4153/4885CA9 3782/4885 |
| US-20110034423-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ADRA1A, ADRA2A, ADRA1D | KIF11 3234/4885CA12 4153/4885CA9 3782/4885 |
| US-20160082007-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ADRA1A, ADRA2A, ADRA1D | KIF11 3234/4885CA12 4153/4885CA9 3782/4885 |
| US-20110027201-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ADRA1A, ADRA2A, ADRA1D | KIF11 3234/4885CA12 4153/4885CA9 3782/4885 |
| US-20100233109-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ADRA1A, ADRA2A, ADRA1D | KIF11 3234/4885CA12 4153/4885CA9 3782/4885 |
| US-20130195944-A1 | METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS | ADRA1A, ADRA2A, ADRA1D | KIF11 3234/4885CA12 4153/4885CA9 3782/4885 |
| US-20190008857-A1 | Method and Therapeutic/Cosmetic Topical Compositions for the Treatment of Rosacea and Skin Erythema Using A1-Adrenoceptor Agonists | ADRA1A, ADRA2A, ADRA1D | KIF11 3234/4885CA12 4153/4885CA9 3782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.